AsperulosideCAS# 14259-45-1 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 14259-45-1 | SDF | Download SDF |
PubChem ID | 84298 | Appearance | White powder |
Formula | C18H22O11 | M.Wt | 414.4 |
Type of Compound | Iridoids | Storage | Desiccate at -20°C |
Solubility | Soluble in methanol and water | ||
SMILES | CC(=O)OCC1=CC2C3C1C(OC=C3C(=O)O2)OC4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | IBIPGYWNOBGEMH-DILZHRMZSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Asperuloside exerts its anti-inflammatory effect in correlation with inhibition of a pro-inflammatory mediator through suppressing nuclear factor kappa-B (NF-κB) nuclear translocation and MAPK phosphorylation in a dose-dependent manner. Chronic administration of Asperuloside stimulates anti-obesity and anti-metabolic syndrome activity in HFD-fed rats across several organs, similar to Eucommia leaf extract (ELE) administration. |
Targets | Glut | TNF-α | ERK | JNK | p38MAPK | NF-kB | IL Receptor |
In vitro | Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.[Pubmed: 26710167 ]Int. Immunopharmacol., 2016 Feb;31:109-15.Asperuloside, an iridoid glycoside found in Herba Paederiae, is a component from traditional Chinese herbal medicine. |
In vivo | Asperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activity.[Pubmed: 25191539]J Nutr Sci. 2012 Sep 5;1:e10.Eucommia leaves (Eucommia ulmoides Oliver) contain chlorogenic acid (a caffeic acid derivative) and geniposidic acid and Asperuloside (ASP), iridoid glucosides used in beverages. |
Structure Identification | Nat Prod Res. 2014;28(8):586-8.Monoterpenoids glycosides content from two Mediterranean populations of Crucianella maritima L.[Pubmed: 24499293]
|
Asperuloside Dilution Calculator
Asperuloside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4131 mL | 12.0656 mL | 24.1313 mL | 48.2625 mL | 60.3282 mL |
5 mM | 0.4826 mL | 2.4131 mL | 4.8263 mL | 9.6525 mL | 12.0656 mL |
10 mM | 0.2413 mL | 1.2066 mL | 2.4131 mL | 4.8263 mL | 6.0328 mL |
50 mM | 0.0483 mL | 0.2413 mL | 0.4826 mL | 0.9653 mL | 1.2066 mL |
100 mM | 0.0241 mL | 0.1207 mL | 0.2413 mL | 0.4826 mL | 0.6033 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Calanolide E
Catalog No.:BCN6230
CAS No.:142566-61-8
- Glyasperin D
Catalog No.:BCN6836
CAS No.:142561-10-2
- A 484954
Catalog No.:BCC6203
CAS No.:142557-61-7
- Sageone
Catalog No.:BCN3144
CAS No.:142546-15-4
- Cimidahurinine
Catalog No.:BCN6229
CAS No.:142542-89-0
- 1,2,3,4,7-Pentamethoxy-9H-xanthen-9-one
Catalog No.:BCN1570
CAS No.:14254-96-7
- L-690,330
Catalog No.:BCC5666
CAS No.:142523-38-4
- L-690,488
Catalog No.:BCC5667
CAS No.:142523-14-6
- MK-5172 sodium salt
Catalog No.:BCC1765
CAS No.:1425038-27-2
- 19-Nortestosterone acetate
Catalog No.:BCC8445
CAS No.:1425-10-1
- Glyasperin A
Catalog No.:BCN6228
CAS No.:142474-52-0
- 3-O-beta-D-apiofuranosyl(1-2)-beta-D-glucopyranosyl rhamnocitrin 4-O-beta-D-glucopyranoside
Catalog No.:BCN8141
CAS No.:142473-99-2
- Narirutin
Catalog No.:BCN6300
CAS No.:14259-46-2
- Didymin
Catalog No.:BCN3327
CAS No.:14259-47-3
- Deacetylasperulosidic acid
Catalog No.:BCN3323
CAS No.:14259-55-3
- Daphylloside
Catalog No.:BCN6232
CAS No.:14260-99-2
- Macrocarpal C
Catalog No.:BCN6233
CAS No.:142628-53-3
- Macrocarpal E
Catalog No.:BCN6234
CAS No.:142628-54-4
- Macrocarpal D
Catalog No.:BCN6235
CAS No.:142647-71-0
- 6-Hydroxykaempferol 3,6-diglucoside
Catalog No.:BCN3335
CAS No.:142674-16-6
- Genkwanol B
Catalog No.:BCN8013
CAS No.:142674-67-7
- Macrocarpal B
Catalog No.:BCN6236
CAS No.:142698-60-0
- CP 100356 hydrochloride
Catalog No.:BCC7882
CAS No.:142715-48-8
- Dihydrocurcumenone
Catalog No.:BCN3557
CAS No.:142717-57-5
Asperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activity.[Pubmed:25191539]
J Nutr Sci. 2012 Sep 5;1:e10.
Eucommia leaves (Eucommia ulmoides Oliver) contain chlorogenic acid (a caffeic acid derivative) and geniposidic acid and Asperuloside (ASP), iridoid glucosides used in beverages. We used a metabolic syndrome rat model, produced by feeding a 35 % high-fat diet (HFD), to examine potential anti-obesity and anti-metabolic syndrome effects and mechanisms of chronic administration of ASP. These effects were compared with Eucommia leaf extract (ELE), the positive control, which exhibits anti-obesity effects. A total of six rats were studied for 3 months in five groups. ASP suppressed body weight, visceral fat weight, food intake and circulating levels of glucose, insulin and lipids, and increased the plasma adiponectin level in rats on a HFD. These effects are similar to those of ELE, except for the influence on the plasma glucose level. RT-PCR studies showed that ASP (like ELE with known anti-obesity effects) diminished isocitrate dehydrogenase 3alpha, NADH dehydrogenase flavoprotein 1 (Comp I) mRNA and fatty acid synthase levels (white adipose tissue), increased carnitine palmitoyltransferase 1alpha and acyl-CoA dehydrogenase, very-long-chain mRNA levels (liver), and increased Glut4, citrate synthase, isocitrate dehydrogenase 3alpha, succinyl CoA synthase, peroxisomal 3-ketoacyl-CoA thiolase, dihydrolipoamide succinyl transferase and succinate dehydrogenase mRNA levels (skeletal muscle) under HFD conditions. Interestingly, ASP administration resulted in significantly increased mRNA levels of uncoupling protein 1 (UCP1) in the brown adipose tissue of HFD-fed rats; ELE did not affect the expression of UCP1. The increased expression of UCP1 may be negated by many ingredients other than ASP in the ELE. These findings suggest that chronic administration of ASP stimulates anti-obesity and anti-metabolic syndrome activity in HFD-fed rats across several organs, similar to ELE administration; thus, ASP may be an important ingredient of ELE.
Monoterpenoids glycosides content from two Mediterranean populations of Crucianella maritima L.[Pubmed:24499293]
Nat Prod Res. 2014;28(8):586-8.
In this study, the iridoidic content of two accessions of Crucianella maritima L., one from Sardinia and the second from Latium, was examined and compared. From a qualitative point of view, the iridoidic pattern of the two samples was similar, since the same compounds (Asperuloside, asperulosidic acid and deacetyl asperulosidic acid) were isolated. Asperuloside was the main compound in both accessions. Asperulosidic acid was the second compound in the accession from Sardinia, while the accession from Latium exhibited a similar amount of asperulosidic acid and deacetyl asperulosidic acid. These iridoids can be considered as chemotaxonomic markers for parts of the Rubiaceae family, in particular for the Rubioideae subfamily to which C. maritima belongs.
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-kappaB signaling in a murine model.[Pubmed:26710167]
Int Immunopharmacol. 2016 Feb;31:109-15.
Asperuloside, an iridoid glycoside found in Herba Paederiae, is a component from traditional Chinese herbal medicine. In this study, we aimed to investigate the protective effects and potential mechanisms of Asperuloside action on inflammatory responses in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells and an LPS-induced lung injury model. The pro-inflammatory cytokines and signaling pathways were measured by enzyme-linked immunosorbent assays (ELISA) and Western blotting to determine the effects of Asperuloside. We found that Asperuloside can significantly downregulate tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1beta, and IL-6 levels in vitro and in vivo, and treatment with Asperuloside significantly reduced the lung wet-to-dry weight, histological alterations and myeloperoxidase activity in a murine model of LPS-induced acute lung injury (ALI). In addition, Western blot analysis that pretreatment with Asperuloside remarkably blunted the phosphorylation of inhibitor of nuclear factor kappa-B (IkappaBalpha), extracellular signal-related kinases 1 and 2 (ERK1/2), c-Jun. N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38MAPK) in LPS-stimulated inflammation. These results indicate that Asperuloside exerts its anti-inflammatory effect in correlation with inhibition of a pro-inflammatory mediator through suppressing nuclear factor kappa-B (NF-kappaB) nuclear translocation and MAPK phosphorylation in a dose-dependent manner.